Does GLOFITAMAB-GXBM Cause Disease progression? 68 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 68 reports of Disease progression have been filed in association with GLOFITAMAB-GXBM. This represents 13.7% of all adverse event reports for GLOFITAMAB-GXBM.
68
Reports of Disease progression with GLOFITAMAB-GXBM
13.7%
of all GLOFITAMAB-GXBM reports
40
Deaths
13
Hospitalizations
How Dangerous Is Disease progression From GLOFITAMAB-GXBM?
Of the 68 reports, 40 (58.8%) resulted in death, 13 (19.1%) required hospitalization, and 1 (1.5%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLOFITAMAB-GXBM. However, 68 reports have been filed with the FAERS database.
What Other Side Effects Does GLOFITAMAB-GXBM Cause?
Cytokine release syndrome (107)
Off label use (68)
Death (67)
Pyrexia (45)
No adverse event (28)
Immune effector cell-associated neurotoxicity syndrome (25)
Infection (20)
Pneumonia (14)
Condition aggravated (12)
Covid-19 (10)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which GLOFITAMAB-GXBM Alternatives Have Lower Disease progression Risk?
GLOFITAMAB-GXBM vs GLUCAGON
GLOFITAMAB-GXBM vs GLUCAGON\GLUCAGON\WATER
GLOFITAMAB-GXBM vs GLUCARPIDASE
GLOFITAMAB-GXBM vs GLUCOPHAGE
GLOFITAMAB-GXBM vs GLUCOSAMINE